Standardizing Potency & LNP Characterization for In-Vivo Gene Editing mRNA

  • Define phase-appropriate potency strategies for editor mRNA payloads to generate data regulators will trust across IND through late stage
  • Align LNP single-particle and bulk characterization readouts to improve cross-site comparability and decision-making
  • Prioritize release and stability assays that balance scientific depth with QC practicality to accelerate clinical readiness